Gianmarco Gioia, FRM, SCR, CFA ESG

Biocentis is an Imperial College London spin-out on a mission to develop eco-friendly genetic solutions to effectively and safely control the dangerous insect species that spread disease to humans, reduce biodiversity, or threaten food security. We leverage CRISPR to develop self-limiting gene drive technologies that are biological, environmentally friendly, and can be tailored to obtain levels of control that are suitable for a broad range of applications. Building on a unique proprietary technological platform, invented by our founders at Imperial College London and applicable to all insect species, Biocentis aims to re-imagine the future of biocontrol. We want to empower communities around the world to tackle the most dangerous insect vectors of disease, to preserve biodiversity and to protect agricultural crops from harmful insect pests. Our vision is a more sustainable world, capable of feeding a growing population and free of vector-borne disease. With offices in Milan and London and a presence in the US, we employ a diverse and accomplished team with unparalleled experience in the scientific and technological fields and an outstanding track record in company building and management. We are also growing very fast, and we encourage you to reach out if you want to be part of our journey.

Choose from a range of our bespoke services to get exactly the kind of experience you want: 🔸 Moving with transparent pricing 🔸 Secure storage with collection & delivery 🔸 End-of-tenancy cleaning 🔸 Full packing supplies

We are a new-generation wholesaler. We serve our customers with the goal of helping them thrive.

At Novaterra, we classify breakthrough technology as innovations that solve fundamental problems or open new possibilities. These technologies offer transformative solutions to significant issues or have the potential to redefine industries. The largest companies of our time will create breakthrough technologies that solve systemic problems profitably and at scale. We define these companies as Impactful, as they deliver impact at scale. Investing, for us, is more than a financial tool; its about nurturing ideas that bring significant positive change. Our commitment is to lead in identifying and nurturing the innovations that will define the future. We focus on two areas where trillion-dollar opportunities driving significant impact could emerge in the next ten years. Planet Health Decarbonisation and climate-change mitigation are crucial to preserving our planet. We envision a future where industries are fully electrified, energy is renewable, the food system is self-sustainable, and agriculture is resilient. Human Preservation We believe in a world where every human has the highest probability of survival and well-being. We invest in advancements that lead to healthier lives, from drug discovery to technologies revolutionising patient care, from alternative living forms to new cures. Our mission is to redefine venture capital by returning to its roots—backing ventures that offer genuine technological innovation and transformative impact. At Novaterra, we aim to generate attractive returns while significantly contributing to societal well-being, ensuring that progress, sustainability, and human advancement are at the forefront of our investment strategy.

Biocentis is an Imperial College London spin-out on a mission to develop eco-friendly genetic solutions to effectively and safely control the dangerous insect species that spread disease to humans, reduce biodiversity, or threaten food security. We leverage CRISPR to develop self-limiting gene drive technologies that are biological, environmentally friendly, and can be tailored to obtain levels of control that are suitable for a broad range of applications. Building on a unique proprietary technological platform, invented by our founders at Imperial College London and applicable to all insect species, Biocentis aims to re-imagine the future of biocontrol. We want to empower communities around the world to tackle the most dangerous insect vectors of disease, to preserve biodiversity and to protect agricultural crops from harmful insect pests. Our vision is a more sustainable world, capable of feeding a growing population and free of vector-borne disease. With offices in Milan and London and a presence in the US, we employ a diverse and accomplished team with unparalleled experience in the scientific and technological fields and an outstanding track record in company building and management. We are also growing very fast, and we encourage you to reach out if you want to be part of our journey.

Choose from a range of our bespoke services to get exactly the kind of experience you want: 🔸 Moving with transparent pricing 🔸 Secure storage with collection & delivery 🔸 End-of-tenancy cleaning 🔸 Full packing supplies

We are a new-generation wholesaler. We serve our customers with the goal of helping them thrive.

At Novaterra, we classify breakthrough technology as innovations that solve fundamental problems or open new possibilities. These technologies offer transformative solutions to significant issues or have the potential to redefine industries. The largest companies of our time will create breakthrough technologies that solve systemic problems profitably and at scale. We define these companies as Impactful, as they deliver impact at scale. Investing, for us, is more than a financial tool; its about nurturing ideas that bring significant positive change. Our commitment is to lead in identifying and nurturing the innovations that will define the future. We focus on two areas where trillion-dollar opportunities driving significant impact could emerge in the next ten years. Planet Health Decarbonisation and climate-change mitigation are crucial to preserving our planet. We envision a future where industries are fully electrified, energy is renewable, the food system is self-sustainable, and agriculture is resilient. Human Preservation We believe in a world where every human has the highest probability of survival and well-being. We invest in advancements that lead to healthier lives, from drug discovery to technologies revolutionising patient care, from alternative living forms to new cures. Our mission is to redefine venture capital by returning to its roots—backing ventures that offer genuine technological innovation and transformative impact. At Novaterra, we aim to generate attractive returns while significantly contributing to societal well-being, ensuring that progress, sustainability, and human advancement are at the forefront of our investment strategy.